155 related articles for article (PubMed ID: 25573056)
1. Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications.
Cary C; Masterson TA; Bihrle R; Foster RS
Urol Oncol; 2015 Sep; 33(9):389.e15-21. PubMed ID: 25573056
[TBL] [Abstract][Full Text] [Related]
2. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
4. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
5. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
7. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Brown JA; Bihrle R; Foster RS
Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
[TBL] [Abstract][Full Text] [Related]
8. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
Considine S; Heaney R; Conroy R; Thornhill JA
Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
[TBL] [Abstract][Full Text] [Related]
9. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.
Williams SB; McDermott DW; Winston D; Bahnson E; Berry AM; Steele GS; Richie JP
BJU Int; 2010 Apr; 105(7):918-21. PubMed ID: 19747353
[TBL] [Abstract][Full Text] [Related]
10. Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.
Calestroupat JP; Sanchez-Salas R; Cathelineau X; Rozet F; Galiano M; Smyth G; Kasraeian A; Barret E; Vallancien G
J Endourol; 2009 Apr; 23(4):645-50. PubMed ID: 19335332
[TBL] [Abstract][Full Text] [Related]
11. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
Macleod LC; Rajanahally S; Nayak JG; Parent BA; Ramos JD; Schade GR; Holt SK; Dash A; Gore JL; Lin DW
Urology; 2016 May; 91():70-6. PubMed ID: 26802801
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
[TBL] [Abstract][Full Text] [Related]
14. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
Spiess PE; Tannir NM; Tu SM; Brown GA; Liu P; Kamat AM; Wood CG; Evans JG; Pisters LL
Cancer; 2007 Dec; 110(12):2700-8. PubMed ID: 17948916
[TBL] [Abstract][Full Text] [Related]
15. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.
Nguyen CT; Stephenson AJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantation.
Cary C; Pedrosa JA; Jacob J; Beck SD; Rice KR; Einhorn LH; Foster RS
Cancer; 2015 Dec; 121(24):4369-75. PubMed ID: 26371446
[TBL] [Abstract][Full Text] [Related]
18. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
20. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
